Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: A nationwide cohort study

Clinical Infectious Diseases

Volumn 57, Issue 12, 2013, Pages 1695-1702

  Huang, Yi Wen ^a,b,c,d   Wang, Ting Chuan ^a   Lin, Shih Chang ^a   Chang, Han Yu ^a   Chen, Ding Shinn ^c,d   Hu, Jui Ting ^a,e   Yang, Sien Sing ^a,e   Kao, Jia Horng ^c,d,f  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^f Hepatitis Research Center   (Taiwan)

Author keywords

comorbidity; database; decompensated cirrhosis; population; time relationship

Indexed keywords

ADEFOVIR DIPIVOXIL; ENTECAVIR; INTERFERON; LAMIVUDINE; TELBIVUDINE; TENOFOVIR;

ADULT; AGE; AGED; AMBULATORY CARE; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; DECOMPENSATED LIVER CIRRHOSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEPATITIS B; HIGH RISK PATIENT; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REIMBURSEMENT; SEX; TAIWAN;

COMORBIDITY; DATABASE; DECOMPENSATED CIRRHOSIS; POPULATION; TIME-RELATIONSHIP;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RISK FACTORS; TAIWAN; YOUNG ADULT;

EID: 84886693658     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit603     Document Type: Article

References (24)

1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis, 2002; 2:395-403
2. Chen DS. From hepatitis to hepatoma: Lessons from type B viral hepatitis. Science 1993; 262:369-70
3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11:97-107
4. Huo TI, Wu JC, Lee PC, Tsay SH, Chang FY, Lee SD. Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection. J Clin Gastroenterol 2000; 30:250-4
5. Custro N, Carroccio A, Ganci A, et al. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab 2001; 27: 476-81
6. Huo T, Wu JC, Hwang SJ, et al. Factors predictive of liver cirrhosis in patients with chronic hepatitis B: A multivariate analysis in a longitudinal study. Eur J Gastroenterol Hepatol 2000; 12:687-93
7. Papatheodoridis GV, Chrysanthos N, Savvas S, et al. Diabetes mellitus in chronic hepatitis B and C: Prevalence and potential association with the extent of liver fibrosis. J Viral Hepat 2006; 13:303-10
8. Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 1967; 2:1051-6
9. Kingston ME, Ali MA, Atiyeh M, Donnelly RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984; 87: 688-94
10. Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus.World J Gastroenterol 2011; 17:5240-5
11. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292:771-4
12. Ko YC, Li SC, Yen YY, Yeh SM, Hsieh CC. Horizontal transmission of hepatitis B virus from siblings and intramuscular injection among preschool children in a familial cohort. Am J Epidemiol 1991; 133: 1015-23
13. Hsu SC, Chang MH, Ni YH, Hsu HY, Lee CY. Horizontal transmission of hepatitis B virus in children. J Pediatr Gastroenterol Nutr 1993; 16:66-9
14. Liu J, Yang HI, Lee MH, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: A community-based follow-up study. Gastroenterology 2010; 139:474-82
15. Tseng TC, Liu CJ, Su TH, et al. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. Gastroenterology 2011; 141:517-25
16. Tseng TC, Liu CJ, Yang HC, et al. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology 2012; 55:68-76
17. National Health Insurance Research Database. Taiwan: data subsets. Available at: Http://w3.nhri.org.tw/nhird/en/Data-Subsets.html#S2. Accessed 15 May 2011
18. World Health Organization Collaborating Centre for Drug Statistics Methodology/ Norwegian Institute of Public Health. ATC/DDD Index 2013. Available at: Http://www.whocc.no/atc-ddd-index/. Accessed 4 January 2012
19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-9
20. Chen YW, Chen HH,Wang TE, et al. The dissociation between the diabetes and both Child-Pugh score and in-hospital mortality in cirrhotic patients due to hepatitis B, hepatitis C, or alcoholic. Hepatol Int 2011; 5:955-64
21. Amarapurkar D, Das HS. Chronic liver disease in diabetes mellitus. Trop Gastroenterol 2002; 23:3-5
22. Falchuk KR, Fiske SC, Haggitt RC, Federman M, Trey C. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology 1980; 78:535-41
23. El-serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126:460-8
24. Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: Meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol 2011; 26:1361-7